So, we have 5,000mcg of BPC-157 in 200 units of solution
That question gets much less attention, and this article maps the terrain of both
Specifically, a nested casecontrol study encompassing all antidiabetic drugs in the Danish population showed a lower OR for major CI among individuals exposed to GLP-1a in comparison to those not exposed to pharmacological treatment for type-2 diabetes (OR: 0.58
In October 2024, the FDA announced that the shortage of tirzepatide, the active ingredient in Mounjaro and Zepbound, was resolved, and shortages of other GLP-1s are also poised to be resolved in the near future
BPC 157 peptide may help tip the balance back toward regeneration, supporting the integrity of tight junctions between intestinal cells and reducing inflammatory markers that perpetuate gut dysfunction
See Fig